Clinical Trial Update: Placebo Controlled Study to Generate Data Characterising Safety Parameters and Immune Responses [Phase 4]

View source ↗

Summary

Phase 4 placebo-controlled trial completed to characterize safety parameters and immune responses for Bordetella pertussis infection prevention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pertussis Prevention

Snippet

Sponsor: University Hospital, Ghent | Conditions: Prevention of Infections With Bordetella Pertussis | Phase 4 | Status: COMPLETED